Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
| 21 | DE file number | DAKZ | 694 35 220.9 |
| 96 | EP file number | EAKZ | 00 10 8479.7 |
| 97 | EP publication number | EPN | 1020460 |
| 54 | Designation/title | TI | Das Natrium Salz des (-)-Enantiomer von Omeprazole |
| 51 | IPC main class | ICM
(ICMV) | C07D 401/12 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/44 (2006.01), A61P 1/04 (2006.01) |
| 22 | DE application date | DAT | May 27, 1994 |
| 96 | EP application date | EAT | May 27, 1994 |
| 43 | Date of first publication | OT | Jul 19, 2000 |
| Date of publication of grant | PET | Jul 22, 2009 |
| 71/73 | Applicant/owner | INH | AstraZeneca AB, 15185 Södertälje, SE |
| 72 | Inventor | IN | Lindberg, Per Lennart, 431 51 Mölndal, SE; Von Unge, Svenker, 430 33 Fjäras, SE |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| SE
9301830
May 28, 1993
|
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
| Published EP/WO documents | EPWOPN | Original document:
EP000001020460
Searchable text:
EP000001020460
Original document:
EP000001020460B1
Searchable text:
EP000001020460B1 |
| 43 | Date of first publication | EVT | Jul 19, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 30, 2022
(Show all update days)(Hide all update days)- Apr 30, 2022; Aug 21, 2019; Aug 6, 2019; Nov 15, 2017; May 29, 2014; Jul 25, 2013; Jun 7, 2013; Jan 22, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
